Not Rated
|
Fund Size
(0.54% of Investment in Category)
|
Expense Ratio
(0.89% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 03-Nov-25 | 9888.90 | -1.11% | - | -1.13% | 105/231 |
| 1 Month | 10-Oct-25 | 9943.10 | -0.57% | - | 0.68% | 181/226 |
| 3 Month | 08-Aug-25 | 10325.60 | 3.26% | - | 5.14% | 182/224 |
| 6 Month | 09-May-25 | 10933.20 | 9.33% | - | 11.20% | 135/213 |
| YTD | 01-Jan-25 | 9870.80 | -1.29% | - | 4.60% | 148/201 |
| 1 Year | 08-Nov-24 | 10213.30 | 2.13% | 2.12% | 4.43% | 121/187 |
| 2 Year | 10-Nov-23 | 15089.80 | 50.90% | 22.81% | 20.29% | 42/141 |
| 3 Year | 10-Nov-22 | 18587.70 | 85.88% | 22.93% | 20.36% | 34/117 |
| 5 Year | 10-Nov-20 | 24870.00 | 148.70% | 19.98% | 22.47% | 54/93 |
| Since Inception | 02-Jul-18 | 42967.90 | 329.68% | 21.89% | 14.07% | 25/198 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 08-Nov-24 | 12000 | 12534.12 | 4.45 % | 8.3 % |
| 2 Year | 10-Nov-23 | 24000 | 27465.68 | 14.44 % | 13.52 % |
| 3 Year | 10-Nov-22 | 36000 | 49093.85 | 36.37 % | 21.17 % |
| 5 Year | 10-Nov-20 | 60000 | 95283.95 | 58.81 % | 18.53 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 3195.6 | 11.57% | 0.65% | 12.5% (Apr 2025) | 10.74% (Jul 2025) | 20.04 L | 90.00 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 2143.1 | 7.76% | -0.39% | 8.53% (Jun 2025) | 4.96% (Oct 2024) | 3.77 L | 5.00 k |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1925.5 | 6.97% | 0.19% | 7.24% (Jul 2025) | 5.22% (Apr 2025) | 9.86 L | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 1719.2 | 6.23% | -0.09% | 6.37% (Jun 2025) | 4.82% (Dec 2024) | 2.32 L | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 1665.8 | 6.03% | -0.27% | 7.6% (Feb 2025) | 6.03% (Sep 2025) | 11.08 L | 0.00 |
| Lupin Ltd. | Pharmaceuticals | 1393.7 | 5.05% | 0.10% | 6.37% (Apr 2025) | 4.94% (Jul 2025) | 7.29 L | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 1195.1 | 4.33% | -1.69% | 8.05% (Oct 2024) | 4.33% (Sep 2025) | 11.03 L | -5.33 L |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 1158.2 | 4.19% | -0.07% | 6.38% (Dec 2024) | 4.13% (Jul 2025) | 9.46 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 1157.1 | 4.19% | 0.30% | 4.19% (Sep 2025) | 2.12% (Jan 2025) | 11.93 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 1033.2 | 3.74% | -0.08% | 4.32% (Nov 2024) | 3.57% (Feb 2025) | 14.76 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.25% |
| MF Units | MF Units | 0.01% |
| Net Receivables | Net Receivables | -0.15% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
Out of 51 mutual fund schemes offered by this AMC, 3 is/are ranked 5 * , 4 is/are ranked 4 * , 4 is/are ranked 3 * , 4 is/are ranked 2 * , and 36 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Large Cap Fund - Direct Plan - Growth | 3 | 41087.55 | 1.30 | 5.31 | 9.19 | 7.42 | 14.23 |
| Mirae Asset Large & Midcap Fund - Direct Plan - Growth | 3 | 40821.90 | 1.79 | 7.35 | 13.77 | 7.74 | 18.50 |
| Mirae Asset ELSS Tax Saver Fund - Direct Plan - Growth | 4 | 25910.64 | 1.42 | 6.47 | 12.09 | 8.23 | 18.64 |
| Mirae Asset Midcap Fund - Direct Plan - Growth | 3 | 17194.25 | 2.23 | 8.34 | 19.66 | 9.14 | 21.96 |
| Mirae Asset Liquid Fund - Direct Plan - Growth | 4 | 11367.77 | 0.49 | 1.46 | 3.06 | 6.75 | 7.09 |
| Mirae Asset Aggressive Hybrid Fund - Direct Plan - Growth | 3 | 9128.00 | 1.19 | 4.62 | 9.19 | 7.97 | 15.18 |
| Mirae Asset Focused Fund - Direct Plan - Growth | 2 | 7769.11 | 0.60 | 4.15 | 9.78 | 3.55 | 13.16 |
| Mirae Asset Great Consumer Fund - Direct Plan - Growth | NA | 4632.32 | -0.56 | 4.65 | 10.36 | 4.07 | 18.60 |
| Mirae Asset Multicap Fund - Direct Plan - Growth | NA | 4126.15 | 1.03 | 5.70 | 13.99 | 7.48 | 0.00 |
| Mirae Asset Arbitrage Fund - Direct Plan - Growth | 2 | 3422.28 | 0.57 | 1.47 | 3.08 | 6.85 | 7.74 |